Metabolic Syndrome and the Role of Dietary Lifestyles in Alzheimer's Disease

Overview

Journal J Neurochem

Specialties Chemistry
Neurology

Date 2008 May 10

PMID 18466323

Citations 54

Authors

Giulio Maria Pasinetti

Jacqueline A Eberstein

Affiliations

Soon will be listed here.

Abstract

Since Alzheimer's disease (AD) has no cure or preventive treatment, an urgent need exists to find a means of preventing, delaying the onset, or reversing the course of the disease. Clinical and epidemiological evidence suggests that lifestyle factors, especially nutrition, may be crucial in controlling AD. Unhealthy lifestyle choices lead to an increasing incidence of obesity, dyslipidemia and hypertension--components of the metabolic syndrome. These disorders can also be linked to AD. Recent research supports the hypothesis that calorie intake, among other non-genetic factors, can influence the risk of clinical dementia. In animal studies, high calorie intake in the form of saturated fat promoted AD-type amyloidosis, while calorie restriction via reduced carbohydrate intake prevented it. Pending further study, it is prudent to recommend to those at risk for AD--e.g. with a family history or features of metabolic syndrome, such as obesity, insulin insensitivity, etc.--to avoid foods and beverages with added sugars; to eat whole, unrefined foods with natural fats, especially fish, nuts and seeds, olives and olive oil; and to minimize foods that disrupt insulin and blood sugar balance.

Citing Articles

The role of cerebrospinal fluid metabolites in mediating the impact of lipids on Late-Onset Alzheimer's Disease: a two-step mendelian randomization analysis.

Jie J, Gong Y, Hu H, Liu S J Transl Med. 2024; 22(1):1077.

PMID: 39609832 PMC: 11603644. DOI: 10.1186/s12967-024-05796-2.

Melatonin rescues pregnant female mice and their juvenile offspring from high fat diet-induced alzheimer disease neuropathy.

Jan A, Shah M, Shah S, Habib S, Ehtesham E, Ahmed N Heliyon. 2024; 10(17):e36921.

PMID: 39281480 PMC: 11395765. DOI: 10.1016/j.heliyon.2024.e36921.

Reversal of high-fat diet-induced cognitive impairment and oxidative stress in the brain through Zingiber officinale supplementation.

Luciano T, Teodoro de Souza C, de Oliveira J, Muller A Metab Brain Dis. 2024; 39(8):1495-1503.

PMID: 39120852 DOI: 10.1007/s11011-024-01406-8.

In the quest for the ideal sweetener: Aspartame exacerbates selected biomarkers in the fruit fly () model of Alzheimer's disease more than sucrose.

Adedayo B, Akinniyi S, Ogunsuyi O, Oboh G Aging Brain. 2023; 4:100090.

PMID: 37559954 PMC: 10407236. DOI: 10.1016/j.nbas.2023.100090.

Alzheimer's Disease Treatment: The Search for a Breakthrough.

Reiss A, Muhieddine D, Jacob B, Mesbah M, Pinkhasov A, Gomolin I Medicina (Kaunas). 2023; 59(6).

PMID: 37374288 PMC: 10302500. DOI: 10.3390/medicina59061084.

References

Young G, Conquer J . Omega-3 fatty acids and neuropsychiatric disorders. Reprod Nutr Dev. 2005; 45(1):1-28. DOI: 10.1051/rnd:2005001. View

Aksenov M, Markesbery W . Changes in thiol content and expression of glutathione redox system genes in the hippocampus and cerebellum in Alzheimer's disease. Neurosci Lett. 2001; 302(2-3):141-5. DOI: 10.1016/s0304-3940(01)01636-6. View

Taniguchi C, Emanuelli B, Kahn C . Critical nodes in signalling pathways: insights into insulin action. Nat Rev Mol Cell Biol. 2006; 7(2):85-96. DOI: 10.1038/nrm1837. View

McMahon J, Green T, Skeaff C, Knight R, Mann J, Williams S . A controlled trial of homocysteine lowering and cognitive performance. N Engl J Med. 2006; 354(26):2764-72. DOI: 10.1056/NEJMoa054025. View

Tomlinson D, Gardiner N . Glucose neurotoxicity. Nat Rev Neurosci. 2007; 9(1):36-45. DOI: 10.1038/nrn2294. View

Kilander L, Nyman H, Boberg M, Hansson L, Lithell H . Hypertension is related to cognitive impairment: a 20-year follow-up of 999 men. Hypertension. 1998; 31(3):780-6. DOI: 10.1161/01.hyp.31.3.780. View

Ringman J, Frautschy S, Cole G, Masterman D, Cummings J . A potential role of the curry spice curcumin in Alzheimer's disease. Curr Alzheimer Res. 2005; 2(2):131-6. PMC: 1702408. DOI: 10.2174/1567205053585882. View

Torpy J, Lynm C, Glass R . JAMA patient page. The metabolic syndrome. JAMA. 2006; 295(7):850. DOI: 10.1001/jama.295.7.850. View

Gasparini L, Gouras G, Wang R, GROSS R, Beal M, Greengard P . Stimulation of beta-amyloid precursor protein trafficking by insulin reduces intraneuronal beta-amyloid and requires mitogen-activated protein kinase signaling. J Neurosci. 2001; 21(8):2561-70. PMC: 6762523. View

10.

Lau F, Shukitt-Hale B, Joseph J . Nutritional intervention in brain aging: reducing the effects of inflammation and oxidative stress. Subcell Biochem. 2007; 42:299-318. View

11.

Ganguli M, Chandra V, Kamboh M, Johnston J, Dodge H, Thelma B . Apolipoprotein E polymorphism and Alzheimer disease: The Indo-US Cross-National Dementia Study. Arch Neurol. 2000; 57(6):824-30. DOI: 10.1001/archneur.57.6.824. View

12.

Arendash G, Jensen M, Salem Jr N, Hussein N, Cracchiolo J, Dickson A . A diet high in omega-3 fatty acids does not improve or protect cognitive performance in Alzheimer's transgenic mice. Neuroscience. 2007; 149(2):286-302. DOI: 10.1016/j.neuroscience.2007.08.018. View

13.

Petot G, Traore F, Debanne S, Lerner A, Smyth K, Friedland R . Interactions of apolipoprotein E genotype and dietary fat intake of healthy older persons during mid-adult life. Metabolism. 2003; 52(3):279-81. DOI: 10.1053/meta.2003.50066. View

14.

Luo Y, Smith J, Paramasivam V, Burdick A, Curry K, Buford J . Inhibition of amyloid-beta aggregation and caspase-3 activation by the Ginkgo biloba extract EGb761. Proc Natl Acad Sci U S A. 2002; 99(19):12197-202. PMC: 129421. DOI: 10.1073/pnas.182425199. View

15.

Dai Q, Borenstein A, Wu Y, Jackson J, Larson E . Fruit and vegetable juices and Alzheimer's disease: the Kame Project. Am J Med. 2006; 119(9):751-9. PMC: 2266591. DOI: 10.1016/j.amjmed.2006.03.045. View

16.

Cao D, Lu H, Lewis T, Li L . Intake of sucrose-sweetened water induces insulin resistance and exacerbates memory deficits and amyloidosis in a transgenic mouse model of Alzheimer disease. J Biol Chem. 2007; 282(50):36275-82. DOI: 10.1074/jbc.M703561200. View

17.

Wang J, Ho L, Zhao Z, Seror I, Humala N, Dickstein D . Moderate consumption of Cabernet Sauvignon attenuates Abeta neuropathology in a mouse model of Alzheimer's disease. FASEB J. 2006; 20(13):2313-20. DOI: 10.1096/fj.06-6281com. View

18.

Miller B, Eckman E, Sambamurti K, Dobbs N, Chow K, Eckman C . Amyloid-beta peptide levels in brain are inversely correlated with insulysin activity levels in vivo. Proc Natl Acad Sci U S A. 2003; 100(10):6221-6. PMC: 156353. DOI: 10.1073/pnas.1031520100. View

19.

Lau F, Shukitt-Hale B, Joseph J . The beneficial effects of fruit polyphenols on brain aging. Neurobiol Aging. 2005; 26 Suppl 1:128-32. DOI: 10.1016/j.neurobiolaging.2005.08.007. View

20.

Le Bars P, Velasco F, Ferguson J, Dessain E, Kieser M, Hoerr R . Influence of the severity of cognitive impairment on the effect of the Gnkgo biloba extract EGb 761 in Alzheimer's disease. Neuropsychobiology. 2002; 45(1):19-26. DOI: 10.1159/000048668. View